Business Context and Reporting Period
This Form 8-K Current Report from Harvard Bioscience, Inc. covers the 2016 Annual Meeting of Stockholders held on June 24, 2016. The filing details the voting results for three specific proposals submitted to security holders.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document is strictly a report on corporate governance voting outcomes.
Material Changes and Voting Results
The following proposals were voted upon and approved by stockholders:
- Proposal 1: Election of Directors
- James W. Green was elected with 19,254,877 votes for and 5,886,593 votes withheld.
- Bertrand Loy was elected with 18,291,981 votes for and 6,849,489 votes withheld.
- Both directors were elected to three-year terms ending in 2019.
- Proposal 2: Ratification of Independent Auditor
- KPMG LLP was ratified as the independent registered public accounting firm for the fiscal year ending December 31, 2016.
- Votes For: 29,482,877; Votes Against: 337,824; Votes Abstained: 227,439.
- Proposal 3: Executive Compensation Advisory Vote
- The compensation of named executive officers was approved via a non-binding advisory vote.
- Votes For: 19,615,480; Votes Against: 5,034,650; Votes Abstained: 491,340.
Guidance, Outlook, and Risks
The filing text does not provide management commentary, financial guidance, outlook, risks, contingencies, or unusual items. The report is limited to the disclosure of voting results.
Key Facts for Investor Verification
- Verify the terms of the newly elected directors (James W. Green and Bertrand Loy) extend through the 2019 annual meeting.
- Confirm KPMG LLP's appointment as the auditor for the fiscal year ending December 31, 2016.
- Note that the executive compensation vote was non-binding advisory in nature.
- Review the significant number of broker non-votes (4,906,670) recorded for the director election and executive compensation proposals.